Taibah University   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Medina Saudi Arabia (2003)

Organization Overview

First Clinical Trial
2015
NCT03783845
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Taibah University | Taibah University,saudi arabia

Active Ingredients

Drugs in Phase 4 Trials (6)

amoxicillin (2 trials)

articaine (Septocaine) (2 trials)

epinephrine (levophed) (2 trials)

metronidazole (flagyl) (2 trials)

plv-2 (1 trial)

prilocaine (citanest) (1 trial)

Drugs in Phase 3 Trials (1)

green tea (1 trial)

Drugs in Phase 2 Trials (1)

COVID-19 convalescent plasma (1 trial)

Drugs in Phase 1 Trials (1)

lidocaine (xylocaine) (1 trial)

Drugs in Other Trials (3)

acetaminophen (tylenol) (1 trial)

chlorhexidine (hibitane) (1 trial)

co-amoxiclav (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Chronic Periodontitis (Phase 4)

Gingivitis (Phase 3)

Periodontitis (Phase 4)

Pulpitis (Phase 1)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 9
  • # of Trial APIs: 12